$MHTX
MANHATTAN SCIENTIFICS INC

2021 Q4 Form 10-Q Financial Statement

#000147793221008408 Filed on November 15, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $0.00 $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $162.0K $175.0K $196.0K
YoY Change -6.36% -10.71% 4.81%
% of Gross Profit
Research & Development $2.000K $3.000K $3.000K
YoY Change 0.0% 0.0%
% of Gross Profit
Depreciation & Amortization $1.000K -$3.000K $1.000K
YoY Change -400.0% -200.0%
% of Gross Profit
Operating Expenses $164.0K $3.000K $3.000K
YoY Change -6.82% 0.0% -98.42%
Operating Profit -$178.0K -$199.0K
YoY Change -10.55%
Interest Expense $130.0K $7.000K $6.000K
YoY Change -95.57% 16.67% -99.57%
% of Operating Profit
Other Income/Expense, Net -$978.0K $1.960M
YoY Change -149.9%
Pretax Income -$34.00K -$1.156M $1.761M
YoY Change -101.23% -165.64% 43.29%
Income Tax
% Of Pretax Income
Net Earnings -$34.00K -$1.156M $1.761M
YoY Change -101.23% -165.64% 43.29%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share -$60.79 $0.00 $2.952K
COMMON SHARES
Basic Shares Outstanding 559.3M shares 559.3M shares 578.4M shares
Diluted Shares Outstanding 559.3M shares 596.5M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $232.0K $366.0K $474.0K
YoY Change -34.28% -22.78% 229.17%
Cash & Equivalents $232.0K $366.0K $474.0K
Short-Term Investments
Other Short-Term Assets $15.00K $7.000K $6.000K
YoY Change 25.0% 16.67% 0.0%
Inventory
Prepaid Expenses $15.00K $7.000K
Receivables
Other Receivables
Total Short-Term Assets $547.0K $673.0K $780.0K
YoY Change -17.74% -13.72% 73.33%
LONG-TERM ASSETS
Property, Plant & Equipment $4.000K $5.000K $6.000K
YoY Change -33.33% -16.67% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.901M $2.806M $2.936M
YoY Change -50.62% -4.43% 38.69%
Other Assets $2.000K $2.000K $2.000K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $2.907M $2.813M $3.244M
YoY Change -52.98% -13.29% 19.05%
TOTAL ASSETS
Total Short-Term Assets $547.0K $673.0K $780.0K
Total Long-Term Assets $2.907M $2.813M $3.244M
Total Assets $3.454M $3.486M $4.024M
YoY Change -49.56% -13.37% 26.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $102.0K $154.0K $1.503M
YoY Change -36.25% -89.75% 534.18%
Accrued Expenses $1.129M $1.081M $790.0K
YoY Change 32.36% 36.84% -55.57%
Deferred Revenue
YoY Change
Short-Term Debt $130.0K $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.361M $1.235M $2.293M
YoY Change 34.49% -46.14% 13.8%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $124.0K $97.00K
YoY Change -100.0% 27.84%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $124.0K $97.00K
YoY Change -100.0% 27.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.361M $1.235M $2.293M
Total Long-Term Liabilities $0.00 $124.0K $97.00K
Total Liabilities $1.361M $1.359M $2.390M
YoY Change 21.95% -43.14% 18.61%
SHAREHOLDERS EQUITY
Retained Earnings -$68.52M -$68.49M
YoY Change 5.61%
Common Stock $559.0K $559.0K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.035M $1.069M $576.0K
YoY Change
Total Liabilities & Shareholders Equity $3.454M $3.486M $4.024M
YoY Change -49.56% -13.37% 26.74%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$34.00K -$1.156M $1.761M
YoY Change -101.23% -165.64% 43.29%
Depreciation, Depletion And Amortization $1.000K -$3.000K $1.000K
YoY Change -400.0% -200.0%
Cash From Operating Activities -$134.0K -$89.00K -$85.00K
YoY Change 10.74% 4.71% -3.41%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $3.000K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $100.0K
YoY Change -100.0% 4900.0%
Cash From Investing Activities $0.00 $3.000K $100.0K
YoY Change -97.0% 4900.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -134.0K -89.00K -85.00K
Cash From Investing Activities 0.000 3.000K 100.0K
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash -134.0K -86.00K 15.00K
YoY Change 10.74% -673.33% -117.44%
FREE CASH FLOW
Cash From Operating Activities -$134.0K -$89.00K -$85.00K
Capital Expenditures $0.00 $3.000K $0.00
Free Cash Flow -$134.0K -$92.00K -$85.00K
YoY Change 10.74% 8.24% -3.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
559281064 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
366000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
353000 USD
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7000 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12000 USD
CY2021Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
300000 USD
CY2020Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
300000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
673000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
665000 USD
CY2021Q3 us-gaap Investments
Investments
2806000 USD
CY2020Q4 us-gaap Investments
Investments
5875000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6000 USD
CY2021Q3 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
0 USD
CY2020Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
300000 USD
CY2021Q3 us-gaap Other Assets
OtherAssets
2000 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
2000 USD
CY2021Q3 us-gaap Assets
Assets
3486000 USD
CY2020Q4 us-gaap Assets
Assets
6848000 USD
CY2021Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
154000 USD
CY2020Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
159000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1081000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
853000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1235000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1012000 USD
CY2021Q3 us-gaap Notes Payable
NotesPayable
124000 USD
CY2020Q4 us-gaap Notes Payable
NotesPayable
104000 USD
CY2020Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
7000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
7000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
6000 USD
us-gaap Interest Expense
InterestExpense
20000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-178000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-199000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-523000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-499000 USD
CY2021Q3 mhtx Gain On Sale Of Investment
GainOnSaleOfInvestment
-978000 USD
CY2020Q3 mhtx Gain On Sale Of Investment
GainOnSaleOfInvestment
1966000 USD
mhtx Gain On Sale Of Investment
GainOnSaleOfInvestment
-3069000 USD
mhtx Gain On Sale Of Investment
GainOnSaleOfInvestment
2075000 USD
CY2021Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
7000 USD
us-gaap Interest Expense
InterestExpense
19000 USD
CY2021Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
124000 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
104000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
1359000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
1116000 USD
CY2021Q3 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
1058000 USD
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
1058000 USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
559281064 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
559281064 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
559000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
559000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
68996000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
68996000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-68486000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-64881000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1069000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
4674000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3486000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6848000 USD
CY2021Q3 us-gaap Revenues
Revenues
0 USD
CY2020Q3 us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
50000 USD
us-gaap Revenues
Revenues
50000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
175000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
196000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
565000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
541000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8000 USD
CY2021Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
178000 USD
CY2020Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
199000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
573000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
549000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-978000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1960000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3082000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2056000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1156000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
1761000 USD
us-gaap Net Income Loss
NetIncomeLoss
-3605000 USD
us-gaap Net Income Loss
NetIncomeLoss
1557000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
559281064 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
559281064 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
578000042 shares
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
559281064 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
596456245 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
559281064 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
596022959 shares
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
4674000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
134000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2583000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
2225000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1156000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1069000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-1005000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-732000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-1737000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
528000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-1209000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
24000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
1761000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
576000 USD
us-gaap Net Income Loss
NetIncomeLoss
-3605000 USD
us-gaap Net Income Loss
NetIncomeLoss
1557000 USD
mhtx Common Stock Issued For Services
CommonStockIssuedForServices
0 USD
mhtx Common Stock Issued For Services
CommonStockIssuedForServices
24000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2000 USD
mhtx Loss Gain On Fair Value Adjustment Of Investments
LossGainOnFairValueAdjustmentOfInvestments
3069000 USD
mhtx Loss Gain On Fair Value Adjustment Of Investments
LossGainOnFairValueAdjustmentOfInvestments
-2075000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
20000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
19000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
7000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-5000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
7000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-12000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
199000 USD
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
228000 USD
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-287000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-267000 USD
mhtx Purchase Of Fixed Assets
PurchaseOfFixedAssets
0 USD
mhtx Purchase Of Fixed Assets
PurchaseOfFixedAssets
-4000 USD
us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
300000 USD
us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
300000 USD
us-gaap Proceeds From Sale Of Investment Projects
ProceedsFromSaleOfInvestmentProjects
0 USD
us-gaap Proceeds From Sale Of Investment Projects
ProceedsFromSaleOfInvestmentProjects
184000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
300000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
480000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
13000 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
213000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
353000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
261000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
366000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
474000 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-68486000 USD
CY2021Q3 mhtx Working Capital
WorkingCapital
-562000 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amount of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. A significant estimate includes the carrying value of the Company’s patents, fair value of the Company’s common stock, assumptions used in calculating the value of stock options, depreciation and amortization.</p>
mhtx Cash Concentration
CashConcentration
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s cash accounts are federally insured up to $250,000 for each financial institution we hold our accounts in. As of September 30, 2021 and December 31, 2020, we had cash balances of $109,000 and $95,000 exceeding the federally insured limits.</p>
CY2021Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
109000 USD
CY2020 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
95000 USD
CY2018 mhtx Adjusted Asset Valuation
AdjustedAssetValuation
1200000 USD
CY2019Q4 mhtx Sale Of Asset
SaleOfAsset
1200000 USD
CY2019 us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
300000 USD
CY2019Q4 mhtx Remaining Amount Of Assets
RemainingAmountOfAssets
900000 USD
CY2020Q2 us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
300000 USD
us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
300000 USD
CY2021Q3 mhtx Common Stock Owned Shares
CommonStockOwnedShares
52516508 shares
us-gaap Business Acquisition Revenue Reported By Acquired Entity For Last Annual Period
BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod
30360 USD
us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
28922917 shares
us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
46397917 shares
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-1156000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
1761000 USD
mhtx Effect Of Dilutive Securities
EffectOfDilutiveSecurities
18012917 shares
CY2021Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
559281064 shares
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
596456245 shares
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2021Q3 us-gaap Earnings Per Share Diluted Distributed
EarningsPerShareDilutedDistributed
-0.00
CY2020Q3 us-gaap Earnings Per Share Diluted Distributed
EarningsPerShareDilutedDistributed
0.00
us-gaap Profit Loss
ProfitLoss
-3605000 USD
us-gaap Profit Loss
ProfitLoss
1557000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
559281064 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
578000042 shares
CY2020Q3 mhtx Effect Of Dilutive Securities
EffectOfDilutiveSecurities
18022917 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
559281064 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
596022959 shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
us-gaap Earnings Per Share Diluted Distributed
EarningsPerShareDilutedDistributed
-0.01
us-gaap Earnings Per Share Diluted Distributed
EarningsPerShareDilutedDistributed
0.00
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
150000 USD
CY2021Q3 mhtx Less Discounts On Notes Payable
LessDiscountsOnNotesPayable
-26000 USD
CY2021Q3 us-gaap Notes Payable
NotesPayable
124000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
15000000 shares
mhtx Number Of Options Granted
NumberOfOptionsGranted
15000000 shares
CY2021Q1 mhtx Closing Market Price Of Common Stock
ClosingMarketPriceOfCommonStock
0.0154
mhtx Weighted Average Contractua Lives Years
WeightedAverageContractuaLivesYears
26500000 shares
CY2021Q3 mhtx Aggregate Intrinsic Value
AggregateIntrinsicValue
238500 USD
CY2020Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
5875000 USD
mhtx Change In The Realized Fair Value Of Securities
ChangeInTheRealizedFairValueOfSecurities
-3069000 USD
CY2021Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
2806000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
20000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
19000 USD
mhtx Schedule Of Debt Discount
ScheduleOfDebtDiscount
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Notes payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">150,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Less: Discounts on notes payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(26,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Notes payable, net of discounts</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">124,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
us-gaap Royalty Expense
RoyaltyExpense
50000 USD
mhtx Number Of Options Outstanding Beginning Balance
NumberOfOptionsOutstandingBeginningBalance
18500000 shares
mhtx Weighted Average Exercise Price Beginning
WeightedAverageExercisePriceBeginning
0.07
mhtx Weighted Average Life Outstanding Beginning Balance
WeightedAverageLifeOutstandingBeginningBalance
P2Y10M2D
mhtx Number Of Options Exercisable Outstanding Beginning Balance
NumberOfOptionsExercisableOutstandingBeginningBalance
18500000 shares
mhtx Aggregate Intrinsic Value Beginning
AggregateIntrinsicValueBeginning
1295000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
15000000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.02
mhtx Weighted Average Life Granted
WeightedAverageLifeGranted
P9Y8M4D
mhtx Share Based Compensation Arrangement By Share Based Payment Award Options Granted Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedExercisableNumber
15000000 shares
mhtx Aggregate Intrinsic Value Granted
AggregateIntrinsicValueGranted
300000 USD
mhtx Share Based Compensation Arrangement By Share Based Payment Award Options Expiration In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationInPeriod
-7000000 shares
mhtx Weighted Average Exercise Price Expired
WeightedAverageExercisePriceExpired
0.07
mhtx Share Based Compensation Arrangement By Share Based Payment Award Options Expired Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredExercisableNumber
-7000000 shares
mhtx Number Of Options Outstanding Ending Balance
NumberOfOptionsOutstandingEndingBalance
26500000 shares
mhtx Weighted Average Exercise Price Outstanding Ending Balance
WeightedAverageExercisePriceOutstandingEndingBalance
0.04
mhtx Weighted Average Life Outstanding Ending Balance
WeightedAverageLifeOutstandingEndingBalance
P6Y7M9D
mhtx Number Of Options Exercisable Outstanding Ending Balance
NumberOfOptionsExercisableOutstandingEndingBalance
26500000 shares
mhtx Aggregate Intrinsic Value Outstanding
AggregateIntrinsicValueOutstanding
1595000 USD
mhtx Royalty Percentage On Dental Products
RoyaltyPercentageOnDentalProducts
0.10 pure
mhtx Royalty Percentage On Other Licensed Products
RoyaltyPercentageOnOtherLicensedProducts
0.05 pure
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
853000 USD

Files In Submission

Name View Source Status
0001477932-21-008408-index-headers.html Edgar Link pending
0001477932-21-008408-index.html Edgar Link pending
0001477932-21-008408.txt Edgar Link pending
0001477932-21-008408-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mhtx-20210930.xsd Edgar Link pending
mhtx-20210930_cal.xml Edgar Link unprocessable
mhtx-20210930_def.xml Edgar Link unprocessable
mhtx-20210930_lab.xml Edgar Link unprocessable
mhtx-20210930_pre.xml Edgar Link unprocessable
mhtx_10q.htm Edgar Link pending
mhtx_10q_htm.xml Edgar Link completed
mhtx_ex311.htm Edgar Link pending
mhtx_ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending